About the Innovator

Dr. Wishart is a Distinguished University Professor and Tier 1 Canada Research Chair (Metabolomics and Medicine) at the University of Alberta (UofA). Born and raised in Alberta and of Métis heritage, he earned a PhD in Molecular Biophysics from Yale University. Widely recognized as a founder of metabolomics, Wishart has led the Human Metabolome Project for >20 years and created the Human Metabolome Database (HMDB), the global reference for human metabolites. He developed open-access resources such as HMDB, DrugBank, MetaboAnalyst, FooDB, and CFMID, transforming biomedical, nutritional and pharmacological research worldwide. Wishart founded Canada’s national metabolomics platform (The Metabolomics Innovation Centre -TMIC), uniting nine institutions and serving hundreds of collaborators globally. His leadership has established metabolomics as the third pillar of ‘omics’ science and expanded precision-health capacity worldwide. Wishart has authored 600+ peer-reviewed papers and founded 11 biotechnology companies, translating metabolomics innovations into diagnostics and digital-health tools. With 150,000+ citations (hindex 151), he ranks among the world’s 100 most influential biological scientists (Clarivate Analytics). His honours include the NSERC Gerhard Herzberg Canada Gold Medal (2025), UofA University Cup (2025), NSERC Brockhouse Prize (2024), UofA J. Gordin Kaplan Award (2023), and Fellowship in the Royal Society of Canada (2017). Through visionary leadership and open-science advocacy, he has made metabolomics a cornerstone of precision medicine, precision nutrition and environmental science.